hengrui glp-1

hengrui glp-1 China Medicine has registered a Phase III, multicenter, randomized, double-blind clinical trial of the GLP-1R/GIPR dual agonist HRS9531 for the treatment of obesity (NCT06396429; HRS9531-301) Kailera Therapeutics | | The

Name: hengrui glp-1 China Medicine has registered a Phase III, multicenter, randomized, double-blind clinical trial of the GLP-1R/GIPR dual agonist HRS9531 for the treatment of obesity (NCT06396429; HRS9531-301) Kailera Therapeutics | | The
Brand: www.consulsalud.app
SKU: 71800322848
Price: 20.82 USD
Availability: InStock
Rating: 4.1782 (9 reviews)

SKU: 71800322848

4.2

EUR20.82 EUR64.82

Pay in 4 interest-free payments of $5.21 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 15 - Aug 20

Description

While GLP-1 itself is not a medication, several drugs called GLP-1 receptor agonists are designed to mimic its effects for treating type 2 diabetes and supporting weight loss

In the SURMOUNT-1 trial, tirzepatide produced average weight reductions of 15.0%, 19.5%, and 20.9% at studied doses compared with 3.1% with placebo over 72 weeks